
The chief executive and chief medical officers of Celyad Oncology discussed the company’s future research and plans.
The chief executive and chief medical officers of Celyad Oncology discussed the company’s future research and plans.
The chief executive and chief medical officers of Celyad Oncology discussed their platform and positive data presented at EHA 2021.
The chief executive and chief medical officer of Celyad Oncology discussed the advantages of allogeneic CAR T therapies over autologous ones.
Published: August 16th 2024 | Updated: August 19th 2024
Published: March 18th 2024 | Updated: June 3rd 2024
Published: December 7th 2024 | Updated:
Published: December 12th 2022 | Updated:
Published: July 14th 2024 | Updated:
Published: May 18th 2023 | Updated: